Erin Lavelle SEC EDGAR Filings (CIK 0001737613)

SEC EDGAR filings, ownership reports, and insider transactions for Erin Lavelle.

Business address
C/O Alder Biopharmaceuticals, Inc., 11804 North Creek Parkway South, Bothell, WA, 98011
Top holdings (ownership)
NLTX and ELYM
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Erin Lavelle has filed 13 SEC EDGAR filings since 18 Apr 2018

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 01 May 2025 29 Apr 2025 001-40544
3 Open Document Open Filing 3 01 May 2025 28 Apr 2025 001-40544
144 Open Document Open Filing 06 Feb 2024
4 Open Document Open Filing FORM 4 SUBMISSION 09 Jun 2023 08 Jun 2023 001-36327
4 Open Document Open Filing FORM 4 SUBMISSION 02 Nov 2022 31 Oct 2022 001-40708
4 Open Document Open Filing FORM 4 SUBMISSION 16 May 2022 12 May 2022 001-36327
4 Open Document Open Filing FORM 4 SUBMISSION 31 Jan 2022 27 Jan 2022 001-40708
3 Open Document Open Filing FORM 3 SUBMISSION 09 Aug 2021 09 Aug 2021 001-40708
4 Open Document Open Filing FORM 4 SUBMISSION 24 Oct 2019 22 Oct 2019 001-36431
4 Open Document Open Filing FORM 4 SUBMISSION 25 Apr 2019 23 Apr 2019 001-36431
4 Open Document Open Filing FORM 4 SUBMISSION 08 Feb 2019 06 Feb 2019 001-36431
4 Open Document Open Filing FORM 4 SUBMISSION 18 Apr 2018 16 Apr 2018 001-36431
3 Open Document Open Filing FORM 3 SUBMISSION 18 Apr 2018 16 Apr 2018 001-36431